At the news
? BULLISHIMPACT 5/10 PRESS-RELEASE filed Sep 1, 2026 at 08:17 ET
Medtronic announced a ~$700M strategic investment in Cornerstone Robotics and a distribution agreement for the Sentire surgical system in select non-U.S. markets. The deal complements Medtronic's existing Hugo platform and expands its robotic surgery portfolio into China, EU, and Singapore, where Sentire is already approved. This is a bolt-on strategic investment, not a transformative acquisition, and is consistent with Medtronic's capital allocation strategy following strong Q1 FY27 results and a raised guidance outlook.
- Medtronic will invest approximately $700M in Cornerstone Robotics.
- Medtronic gains distribution rights for the Sentire surgical system in select non-U.S. markets where it is approved.
- Sentire is already approved in China (2024), the EU (CE Mark, May 2026), and Singapore (May 2026).
- The partnership is framed as complementary to Medtronic's existing Hugo robotic surgery platform.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access